Cargando…
IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway
BACKGROUND: Bone marrow mesenchymal stem cell (BMSC) transplantation represents a promising therapeutic strategy for ischemic heart disease. However, its effects are hampered by the poor viability of transplanted cells and the hostile microenvironment of the ischemic region. Insulin-like growth fact...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953226/ https://www.ncbi.nlm.nih.gov/pubmed/31918758 http://dx.doi.org/10.1186/s13287-019-1544-y |
_version_ | 1783486600133476352 |
---|---|
author | Lin, Mingzhuo Liu, Xinyue Zheng, Haoxiao Huang, Xiaohui Wu, Yu Huang, Anqing Zhu, Hailan Hu, Yunzhao Mai, Weiyi Huang, Yuli |
author_facet | Lin, Mingzhuo Liu, Xinyue Zheng, Haoxiao Huang, Xiaohui Wu, Yu Huang, Anqing Zhu, Hailan Hu, Yunzhao Mai, Weiyi Huang, Yuli |
author_sort | Lin, Mingzhuo |
collection | PubMed |
description | BACKGROUND: Bone marrow mesenchymal stem cell (BMSC) transplantation represents a promising therapeutic strategy for ischemic heart disease. However, its effects are hampered by the poor viability of transplanted cells and the hostile microenvironment of the ischemic region. Insulin-like growth factor-1 (IGF-1) is an important paracrine growth factor of BMSC and plays an important role in the properties of BMSC. Here, we investigated whether overexpressing IGF-1 could enhance the BMSC viability, migration, anti-apoptosis, and protective effects of cardiomyocytes, and explore the underlying mechanisms’ focus on the role of the AKT/secreted frizzled-related protein 2 (SFRP2)/β-catenin pathway. METHODS: We constructed BMSCs overexpressing insulin-like growth factor-1 (BMSCs-IGF-1) or empty vector (BMSCs-NC) using lentivirus, and evaluated cell survival, proliferation, and migration under normoxic and hypoxic conditions. Co-culture of rat cardiomyoblasts with BMSCs was performed to explore the paracrine effect of BMSCs-IGF-1 for rescuing cardiomyoblasts under hypoxia. Transplantation of BMSCs in acute myocardial infarction rats was used to explore the effect of BMSCs-IGF-1 therapy. RESULTS: BMSCs-IGF-1 exhibited a higher cell proliferation rate, migration capacity, and stemness, and were more resistant to apoptosis under hypoxia. Overexpression of IGF-1 upregulated the expression of total and nuclear β-catenin via the AKT-secreted frizzled-related protein 2 (SFRP2) pathway, which enhanced cell survival. Inhibition of AKT or SFRP2 knockdown by siRNA significantly antagonized the effect of IGF-1 and decreased the expression of β-catenin. The expression of β-catenin target genes, including cyclin D1 and c-Myc, were accordingly decreased. Moreover, BMSCs-IGF-1 could rescue cardiomyoblasts from hypoxia-induced apoptosis and preserve cell viability under hypoxia. Transplantation of BMSCs-IGF-1 into myocardial infarction rats greatly reduced infarct volume than BMSCs-NC, with significantly greater expression of SFRP2 and β-catenin. CONCLUSIONS: These results suggest that in BMSCs overexpressing IGF-1, SFRP2 is an important mediator for the enhancement of stem cell viability via activating, rather than antagonizing, the Wnt/β-catenin pathway. |
format | Online Article Text |
id | pubmed-6953226 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-69532262020-01-14 IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway Lin, Mingzhuo Liu, Xinyue Zheng, Haoxiao Huang, Xiaohui Wu, Yu Huang, Anqing Zhu, Hailan Hu, Yunzhao Mai, Weiyi Huang, Yuli Stem Cell Res Ther Research BACKGROUND: Bone marrow mesenchymal stem cell (BMSC) transplantation represents a promising therapeutic strategy for ischemic heart disease. However, its effects are hampered by the poor viability of transplanted cells and the hostile microenvironment of the ischemic region. Insulin-like growth factor-1 (IGF-1) is an important paracrine growth factor of BMSC and plays an important role in the properties of BMSC. Here, we investigated whether overexpressing IGF-1 could enhance the BMSC viability, migration, anti-apoptosis, and protective effects of cardiomyocytes, and explore the underlying mechanisms’ focus on the role of the AKT/secreted frizzled-related protein 2 (SFRP2)/β-catenin pathway. METHODS: We constructed BMSCs overexpressing insulin-like growth factor-1 (BMSCs-IGF-1) or empty vector (BMSCs-NC) using lentivirus, and evaluated cell survival, proliferation, and migration under normoxic and hypoxic conditions. Co-culture of rat cardiomyoblasts with BMSCs was performed to explore the paracrine effect of BMSCs-IGF-1 for rescuing cardiomyoblasts under hypoxia. Transplantation of BMSCs in acute myocardial infarction rats was used to explore the effect of BMSCs-IGF-1 therapy. RESULTS: BMSCs-IGF-1 exhibited a higher cell proliferation rate, migration capacity, and stemness, and were more resistant to apoptosis under hypoxia. Overexpression of IGF-1 upregulated the expression of total and nuclear β-catenin via the AKT-secreted frizzled-related protein 2 (SFRP2) pathway, which enhanced cell survival. Inhibition of AKT or SFRP2 knockdown by siRNA significantly antagonized the effect of IGF-1 and decreased the expression of β-catenin. The expression of β-catenin target genes, including cyclin D1 and c-Myc, were accordingly decreased. Moreover, BMSCs-IGF-1 could rescue cardiomyoblasts from hypoxia-induced apoptosis and preserve cell viability under hypoxia. Transplantation of BMSCs-IGF-1 into myocardial infarction rats greatly reduced infarct volume than BMSCs-NC, with significantly greater expression of SFRP2 and β-catenin. CONCLUSIONS: These results suggest that in BMSCs overexpressing IGF-1, SFRP2 is an important mediator for the enhancement of stem cell viability via activating, rather than antagonizing, the Wnt/β-catenin pathway. BioMed Central 2020-01-09 /pmc/articles/PMC6953226/ /pubmed/31918758 http://dx.doi.org/10.1186/s13287-019-1544-y Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Lin, Mingzhuo Liu, Xinyue Zheng, Haoxiao Huang, Xiaohui Wu, Yu Huang, Anqing Zhu, Hailan Hu, Yunzhao Mai, Weiyi Huang, Yuli IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway |
title | IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway |
title_full | IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway |
title_fullStr | IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway |
title_full_unstemmed | IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway |
title_short | IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway |
title_sort | igf-1 enhances bmsc viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953226/ https://www.ncbi.nlm.nih.gov/pubmed/31918758 http://dx.doi.org/10.1186/s13287-019-1544-y |
work_keys_str_mv | AT linmingzhuo igf1enhancesbmscviabilitymigrationandantiapoptosisinmyocardialinfarctionviasecretedfrizzledrelatedprotein2pathway AT liuxinyue igf1enhancesbmscviabilitymigrationandantiapoptosisinmyocardialinfarctionviasecretedfrizzledrelatedprotein2pathway AT zhenghaoxiao igf1enhancesbmscviabilitymigrationandantiapoptosisinmyocardialinfarctionviasecretedfrizzledrelatedprotein2pathway AT huangxiaohui igf1enhancesbmscviabilitymigrationandantiapoptosisinmyocardialinfarctionviasecretedfrizzledrelatedprotein2pathway AT wuyu igf1enhancesbmscviabilitymigrationandantiapoptosisinmyocardialinfarctionviasecretedfrizzledrelatedprotein2pathway AT huanganqing igf1enhancesbmscviabilitymigrationandantiapoptosisinmyocardialinfarctionviasecretedfrizzledrelatedprotein2pathway AT zhuhailan igf1enhancesbmscviabilitymigrationandantiapoptosisinmyocardialinfarctionviasecretedfrizzledrelatedprotein2pathway AT huyunzhao igf1enhancesbmscviabilitymigrationandantiapoptosisinmyocardialinfarctionviasecretedfrizzledrelatedprotein2pathway AT maiweiyi igf1enhancesbmscviabilitymigrationandantiapoptosisinmyocardialinfarctionviasecretedfrizzledrelatedprotein2pathway AT huangyuli igf1enhancesbmscviabilitymigrationandantiapoptosisinmyocardialinfarctionviasecretedfrizzledrelatedprotein2pathway |